Argent Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Argent Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-54,085	Closed	-$1.05M	–	218
2018 Q1	$1.05M	Buy	+54,085	New	+$1.06M	0.04%	136

Argent Capital Management's IPXL Position: Q2 2018 in Review

Argent Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 54,085 shares — an estimated $1.05M sold.

Argent Capital Management first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $1.05M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Argent Capital Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Argent Capital Management sold 54,085 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.05M.
Argent Capital Management first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
Argent Capital Management's Impax Laboratories, Inc. position peaked at $1.05M in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Argent Capital Management's 13F filing for Q2 2018, filed 9 Aug 2018.